| Literature DB >> 2119218 |
Abstract
In 20 women with menorrhagia (greater than 80 ml blood loss per menstrual period) a levonorgestrel-releasing intrauterine device (Lng-IUCD) was inserted. Menstrual blood loss (MBL) was measured in two consecutive cycles before the device was inserted and after 3, 6 and 12 months of use. MBL was significantly reduced after 3 months (86%) and after 12 months the reduction was 97%. There was a significant increase (P less than 0.001) in serum ferritin during the first year of Lng-IUCD use. The Lng-IUCD seems to be an important alternative to oral medication and to hysterectomy in the treatment of menorrhagia.Entities:
Keywords: Biology; Bleeding--prevention and control; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents--administraction and dosage; Contraceptive Methods; Contraceptive Usage; Data Collection; Developed Countries; Diseases; Europe; Examinations And Diagnoses; Family Planning; Hemic System; Hemoglobin Level--analysis; Iud; Laboratory Examinations And Diagnoses; Levonorgestrel--administraction and dosage; Measurement; Menorrhagia; Menstruation Disorders; Method Acceptability; Northern Europe; Physiology; Research Methodology; Scandinavia; Signs And Symptoms; Sweden; Treatment
Mesh：
Substances：
Year: 1990 PMID： 2119218 DOI： 10.1111/j.1471-0528.1990.tb16240.x
Source DB: PubMed Journal: Br J Obstet Gynaecol ISSN： 0306-5456